Trial record 1 of 2 for:
hart acr16
A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease (HART)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00724048 |
|
Recruitment Status
:
Completed
First Posted
: July 29, 2008
Last Update Posted
: July 22, 2016
|
Sponsor:
Teva Pharmaceutical Industries
Information provided by (Responsible Party):
Teva Pharmaceutical Industries
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 2011 |
| Actual Study Completion Date : | June 2011 |
| Certification/Extension First Submitted : | February 19, 2013 |